The University of Southern California recently shut down it’s kidney transplant unit after implanting a kidney in the wrong patient. An investigation is underway to determine what holes in the program allowed for such horrid medical malpractice. Fortunately, no patient was injured, due to the fortunate fact that the kidney was a universal ‘O‘ blood type. Had that not been the case, someone could have died.
After the error was discovered, the hospital quickly began working to locate an eligible recipient for the additional kidney. Luckily, the intended recipient of the misplaced kidney received an organ just a few days later.
Medical Malpractice Lawyers in New Jersey and Philadelphia
While the patients involved in this potentially fatal mishap remained well and everything turned out okay, these errors occur regularly, and outcomes are not always so positive. Almost 100,000 patients will lose their lives each year to preventable medical errors, and most families won’t see the justice they so clearly deserve.
If you or a loved one have suffered at the hands of a negligent medical provider, contact the Mininno Law Office for a free case evaluation. You may also call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia. Our medical malpractice lawyers are dedicated to earning full and fair compensation for innocent patients victimized by avoidable medical negligence.
Don’t wait, as a statue of limitations may be running out on your claim. Let our team work hard to earn you the compensation you deserve.
It is important, as
Recent news demonstrates that not only are DePuy recall lawyers and patients planning for the litigation, but Johnson & Johnson and DePuy have also recognized the potential problem and have taken financial steps to prepare themselves. According to Johnson & Johnson’s fourth quarter earnings report released this past month, the company is taking a $922 million charge related to its potential exposure for the DePuy hip recall. While $922 million may sound like a large sum of money, it may be inadequate to cover the sum of 93,000 potential claimants that will require compensation from Johnson & Johnson.
Medical students at the University researched and reviewed notes written by American neurosurgeon Harvey Cushing. Cushing is considered the “father of modern neurosurgery” and a pioneer of the brain surgery that we know of today. He developed many of the techniques that neurosurgeons still use, dramatically increasing patient survival rates after such invasive and dangerous procedures on the brain.
A
This for-profit, corporately owned nursing home was cited for a variety of deficiencies from November 2008 through October 2010. The citations were in a wide variety of categories including, among others, nutrition/dietary needs, living environment, and pharmaceutical responsibilities. For example, it indicated that some residents were affected by the fact that the pharmacy made medication errors of more than 5%. These errors are defined as administering the wrong drugs, administering the wrong doses, or administering drugs ate the wrong times. Medication errors can lead to many serious health issues.
As a
On the day of her daughter Cassie’s birth, Dr. Lisa Yang and her colleagues administered drugs and forced the kind of birth deemed nearly impossible early on in Heather’s pregnancy. The drugs administered were supposed to assist the uterus in contracting, and eventually the baby would be expelled. However, because of her mother’s condition, and because of Cassie’s size, which the doctors failed to consider, Cassie’s head became stuck.
For years, the FDA has permitted a regulatory loophole under FDA 510(k) which permits the release of new medical devices like the DePuy hip implant, Zimmer NexGen knee implant, and other medical devices, to be placed onto the market without first receiving a comprehensive review by the FDA. How? Because this loophole permits implant manufacturers, like DePuy, to obtain FDA approval if a medical device manufacturer shows that its device is “substantially equivalent” in safety and effectiveness to another FDA approved device.
Dr. Stephen Serlin was summoned at 5am on February 24th, 1993 to perform an emergency C-section for Marlayna’s mother, Dawn Kineke. He did not arrive at the hospital until 7am, and the procedure didn’t begin until 8:14am. In that time, Marlayna suffered fetal asphyxia from umbilical cord compression within the womb, which caused cerebral palsy and a host of additional developmental issues.